These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15913883)

  • 1. p53 autoantibodies from patients with head and neck cancer recognise common epitopes on the polypeptide chain of p53.
    Saleh J; Brunner C; Gölzer R; Nastainczyk W; Montenarh M
    Cancer Lett; 2006 Feb; 233(1):48-56. PubMed ID: 15913883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 autoantibodies from patients with colorectal cancer recognize common epitopes in the N- or C-terminus of p53.
    Saleh J; Kreissler-Haag D; Montenarh M
    Int J Oncol; 2004 Oct; 25(4):1149-55. PubMed ID: 15375567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-p53 antibodies in serum of smokers and head and neck cancer patients.
    Wollenberg B; Jan NV; Pitzke P; Reiter W; Stieber P
    Anticancer Res; 1997; 17(1A):413-8. PubMed ID: 9066686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
    Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
    Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and neck cancer and p53-immunogenicity.
    Maass JD; Gottschlich S; Goeroegh T; Lippert BM; Werner JA
    Anticancer Res; 1997; 17(4B):2873-4. PubMed ID: 9329551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of serum autoantibodies to tumor suppressor gene p53 with a new enzyme-linked immunosorbent assay in patients with ovarian cancer.
    Marx D; Frey M; Zentgraf H; Adelssen G; Schauer A; Kuhn W; Meden H
    Cancer Detect Prev; 2001; 25(2):117-22. PubMed ID: 11341346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 autoantibodies as tumor marker in head and neck squamous cell cancer.
    Gottschlich S; Hoffmann M; Maass JD; Görörgh T; Buhmann V; Hoffmann-Fazel A; Rudert H; Maune S
    Anticancer Res; 2003; 23(2A):913-5. PubMed ID: 12820322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibody formation to cellular p53 protein in patients with squamous cell carcinomas of the upper respiratory and digestive system].
    Maass JD; Gottschlich S; Lippert BM; Niemann AM; Görögh T; Werner JA
    Laryngorhinootologie; 1996 Jan; 75(1):53-6. PubMed ID: 8851121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to p53 in sera of patients with autoimmune thyroid disease.
    Fenton CL; Patel A; Tuttle RM; Francis GL
    Ann Clin Lab Sci; 2000 Apr; 30(2):179-83. PubMed ID: 10807162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression.
    Creaney J; McLaren BM; Stevenson S; Musk AW; de Klerk N; Robinson BW; Lake RA
    Br J Cancer; 2001 Jan; 84(1):52-6. PubMed ID: 11139313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ribosomal P0 protein induces a spontaneous immune response in patients with head and neck advanced stage carcinoma that is not dependent on its overexpression in carcinomas.
    Bei R; Masuelli L; Trono P; Orvietani PL; Losito S; Marzocchella L; Vitolo D; Albonici L; Mrozek MA; Di Gennaro E; Lista F; Faggioni G; Ionna F; Binaglia L; Manzari V; Budillon A; Modesti A
    Int J Oncol; 2007 Dec; 31(6):1301-8. PubMed ID: 17982655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody against DNA binding helix of p53 protein.
    Yolcu E; Sayan BS; Yağci T; Cetin-Atalay R; Soussi T; Yurdusev N; Ozturk M
    Oncogene; 2001 Mar; 20(11):1398-401. PubMed ID: 11313883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of human antibodies against the central DNA binding domain of p53 from an individual with colorectal cancer using antibody phage display.
    Coomber DW; Ward RL
    Clin Cancer Res; 2001 Sep; 7(9):2802-8. PubMed ID: 11555596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of autoantibodies against p53 in Taiwanese lung cancer patients undergoing chemotherapy.
    Lee YL; Shih CM; Chiou HL; Shiau MY; Chang GC; Chang YH
    Clin Chim Acta; 2004 Nov; 349(1-2):87-96. PubMed ID: 15469860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum anti-p53 antibodies in gastric cancer patients].
    Lawniczak M; Bielicki D; Sulzyc-Bielicka V; Marlicz K; Starzyńska T
    Pol Merkur Lekarski; 2007 Sep; 23(135):192-5. PubMed ID: 18080693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China.
    Qiu LL; Hua PY; Ye LL; Wang YC; Qiu T; Bao HZ; Wang L
    Cancer Detect Prev; 2007; 31(1):45-9. PubMed ID: 17292563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope analysis of the murine p53 tumour suppressor protein.
    Lane DP; Stephen CW; Midgley CA; Sparks A; Hupp TR; Daniels DA; Greaves R; Reid A; Vojtesek B; Picksley SM
    Oncogene; 1996 Jun; 12(11):2461-6. PubMed ID: 8649788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum anti-p53 autoantibodies from patients with idiopathic pulmonary fibrosis associated with lung cancer.
    Oshikawa K; Sugiyama Y
    Respir Med; 2000 Nov; 94(11):1085-91. PubMed ID: 11127496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.